Kigamicin B is a natural product belonging to the class of compounds known as polyketides, which are characterized by their complex structures and diverse biological activities. It is derived from the fermentation of specific strains of bacteria, particularly those in the genus Streptomyces. Kigamicin B exhibits notable antimicrobial properties, making it of interest in pharmaceutical research for potential therapeutic applications. The compound's structure includes multiple functional groups that contribute to its biological activity, including a unique arrangement of carbon rings and substituents. Its mechanism of action often involves interference with cellular processes in target organisms, which can lead to growth inhibition. Additionally, Kigamicin B may possess cytotoxic effects, further highlighting its potential in drug development. As with many natural products, the extraction and purification processes are critical for obtaining Kigamicin B in sufficient quantities for research and potential clinical use. Overall, its unique chemical characteristics and biological activities make Kigamicin B a subject of ongoing scientific investigation.

Kigamicin B

680571-50-0: Kigamicin B is a natural product belonging to the class of compounds known as polyketides, which are characterized by their complex structures and diverse biological activities. It is derived from the fermentation of specific strains of bacteria, particularly those in the genus Streptomyces. Kigamicin B exhibits notable antimicrobial properties, making it of interest in pharmaceutical research for potential therapeutic applications. The compound's structure includes multiple functional groups that contribute to its biological activity, including a unique arrangement of carbon rings and substituents. Its mechanism of action often involves interference with cellular processes in target organisms, which can lead to growth inhibition. Additionally, Kigamicin B may possess cytotoxic effects, further highlighting its potential in drug development. As with many natural products, the extraction and purification processes are critical for obtaining Kigamicin B in sufficient quantities for research and potential clinical use. Overall, its unique chemical characteristics and biological activities make Kigamicin B a subject of ongoing scientific investigation.

<p>Kigamicin B exhibits activity against gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), with a minimum inhibitory concentration (MIC) ranging from 0.025 to 0.78 μg/mL.</p>

CAS 680571-50-0

Kigamicin B

Kigamicin B

Ref: TM-TN10998